FT.com / Search

1-10 of 465,139 results for IN RE: DESLORATADINE PATENT LITIGATION - MDL1851

Sorry, we found no matches with all of your words. Here are the nearest matches with some of the words.

FT Suggests - Try these pages on FT.com

Sort by:

Relevance
Date

January 18, 2010
Nokia victory in IPCom patent suit
...court as highly regarded as the English patent court has made this ruling.“However...highlights the difficulty we have still got in Europe where there are different national jurisdictions for patent litigation ... [We] could still have a situation where the patents do not exist in the UK but do exist elsewhere in Europe... By Andrew Ward in Stockholm and Jane Croft in London
January 19, 2010
Nokia victory in IPCom patent suit
...court as highly regarded as the English patent court has made this ruling. "However...highlights the difficulty we have still got in Europe where there are different national jurisdictions for patent litigation . . . [We] could still have a situation where the patents do not exist in the UK but do exist elsewhere in Europe... By Andrew Ward in Stockholm and Jane Croft in London
December 4, 2009
EU patent overhaul moves closer
...reforming Europe’s cumbersome and costly patent system by approving in principle a specialised litigation system and the creation of a single European Union-wide patent.David Lammy, the UK minister in charge of intellectual property issues...followed by concrete action.“We’re certainly looking forward to a positive... By Nikki Tait in Brussels
January 7, 2010
AstraZeneca settles dispute with Teva
...patents that were under dispute in the litigation were valid, and that were Teva to make...AstraZeneca has complete confidence in patents that protect Nexium, which is why we filed the patent infringement action in the first place...of our shareholders’ investment in Nexium, mitigating uncertainties and...the many other costs associated with patent litigation.”Analysts were pleased with the development...welcome and reduces risk to earnings in 2011 because Teva could have been prepared... By John O’Doherty
January 8, 2010
Settlement with Teva buys time for AstraZeneca
...shareholders' investment in Nexium, mitigating uncertainties...other costs associated with patent litigation." Panmure Gordon, the London...reduce "risk to earnings in 2011". Separately, AstraZeneca has also halted litigation it had been pursuing against...2000 for infringement of its patent on Prilosec, prescribed for... By John O'Doherty
December 4, 2009
Ministers back EU patent reform plan
...reforming Europe’s cumbersome and costly patent system on Friday, by approving in principle a new specialised litigation system and the creation of a single European Union-wide patent.If the proposed changes take effect...businesses could see a significant reduction in the costs of managing their intellectual... By Nikki Tait in Brussels
February 9, 2010
Dispute on patent adds to Toyota's problems
...Russian scientist who emigrated to the US in the late 1970s.Mr Severinsky sought...talks came to nothing.Noting that the patent at the centre of the dispute expires in 2012, Robert Oswald, Paice's chief executive, says "we're all getting older. The patent portfolio is wasting and there has to... By Bernard Simon in Toronto
February 8, 2010
Patent dispute adds to Toyota’s woes
...Russian scientist who emigrated to the US in the late 1970s. Mr Severinsky sought...talks came to nothing. Noting that the patent at the centre of the dispute expires in 2012, Robert Oswald, Paice’s chief executive, says “we’re all getting older. The patent portfolio is wasting and there has to be a... By Bernard Simon in Toronto
April 25, 2006
Drug patent payoffs bring a scrutiny of side-effects
...that resolve complex and expensive patent litigation," he says. Schering echoes that view in its brief, emphasising that without knowing whether the patent itself is valid - something that antitrust...invalidated. Another study found that in patent litigation from 1992 to 2000 between branded... By Stephanie Kirchgaessner and Patti Waldmeir
April 24, 2006
Drug patent payoffs bring scrutiny of side-effects
...that resolve complex and expensive patent litigation,” he says. Schering echoes that view in its brief, emphasising that without knowing whether the patent itself is valid – something that antitrust...invalidated. Another study found that in patent litigation from 1992 to 2000 between branded...